A registry-linked national platform trial to improve precision-based outcomes using novel therapies in acute myeloid leukaemia (AML)

  • Wei, Andrew (Primary Chief Investigator (PCI))
  • Dawson, Mark A. (Chief Investigator (CI))
  • Reynolds, John (Chief Investigator (CI))
  • Bohlander, Stefan K. (Chief Investigator (CI))
  • Ivey, Adam (Chief Investigator (CI))
  • Ekert, Paul (Associate Investigator (AI))
  • Marlton, Paula (Associate Investigator (AI))
  • Blombery, Piers (Associate Investigator (AI))

Project: Research

Project Details

StatusFinished
Effective start/end date13/06/18 → 31/12/23